Advancing ADC Manufacturing with Integrated Solutions for Safety and Improved Process Control
Sponsored content brought to you byWith the precision of monoclonal antibodies and the potency of small-molecular payloads, antibody-drug conjugates (ADC) are promising cancer therapeutics. As of this year, there are 19 ADC drugs available...
TRIMTECH Therapeutics appoints Alison Lawton as Chair of the Board
TRIMTECH Therapeutics, a biotechnology company developing novel small molecule therapies that target and degrade protein aggregates associated with neurodegenerative diseases, today announced the appointment of Alison Lawton as Chair of its Board of Directors....
The Case for Endogenous Tagging
Sponsored content brought to you by
Overcoming artifacts and capturing an accurate view of protein dynamics
Understanding how proteins behave in living systems is central to biology. Yet, for decades, researchers have relied on overexpression models...
Noninvasive blood-glucose monitoring method could replace finger-prick tests for diabetes
A noninvasive method for measuring blood glucose levels, developed at MIT, could save diabetes patients from having to prick their fingers several times a day.
The MIT team used Raman spectroscopy - a technique that...
Stem cells reshape in response to electrical signals, study reveals
Scientists in Melbourne have discovered how tiny electrical pulses can steer stem cells as they grow, opening the door to new improved ways of creating new tissues, organs, nerves and bones. Dr Amy Gelmi,...
AI-assisted liquid biopsies show promise for early cancer detection
The prospect of diagnosing cancer through painless methods - such as a simple AI-assisted blood or urine test that detects tiny particles known as exosomes - is becoming increasingly realistic. Scientists predict that this...
Cracking the Code of Francis Crick
Register Now Panelists:
Matthew Cobb, PhD Professor EmeritusUniversity of Manchester View Bio
Panelist ...
Generative AI aids discovery of ISM3830’s novel scaffold
Casitas B-lineage lymphoma-b (CBLB) is an E3 ubiquitin–protein ligase that functions as an intracellular checkpoint and master negative regulator of T‑cell and natural killer (NK) cell activation, playing a central role in modulating T-cell...
Lundbeck Ends Bidding War for Avadel, After Alkermes’ Up-to-$2.37B Offer
Lundbeck has ended its bidding war with Alkermes to acquire Avadel Pharmaceuticals, saying that it will not increase its offer for the sleep disorder drug developer beyond the approximately $2.4 billion it proposed more than...
Los Angeles wildfires trigger surge in virtual health care usage
When uncontrolled wildfires moved from the foothills above Los Angeles into the densely populated urban areas below in January 2025, evacuation ensued and a thick layer of toxic smoke spread across the region. Air...
